Skip to content

Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period

The Effect of Probiotics in Reducing Infections and Allergic Manifestations in Young Children During the Complementary Feeding Period

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02032056
Acronym
ProbiComp
Enrollment
40
Registered
2014-01-09
Start date
2013-09-30
Completion date
2014-05-31
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy, Days Absent From Day Care, Gastrointestinal Infections, Respiratory Tract Infections

Keywords

Infections, Allergy, Immune function, Microbiota, infant

Brief summary

The aim of the intervention is to examine the effect of the bacterial strain BB-12, provided for 6 mo, on the prevalence of infections and allergic manifestations in small children, and how BB-12 affects the immune system, the gastrointestinal tract and the microbiota. Children are enrolled during 2 winter seasons.

Interventions

DIETARY_SUPPLEMENTProbiotic (10^9 CFU/day)
DIETARY_SUPPLEMENTProbiotic (10^8 CFU/day)
OTHERPlacebo

Sponsors

The Danish Council for Strategic Research
CollaboratorOTHER
Chr Hansen
CollaboratorINDUSTRY
Technical University of Denmark
CollaboratorOTHER
University of Bergen
CollaboratorOTHER
Odense University Hospital
CollaboratorOTHER
Statens Serum Institut
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Months to 13 Months
Healthy volunteers
Yes

Inclusion criteria

* 9 - 12 1/2 month at intervention start * Start in daycare 4 +/- 2 weeks after intervention start * Single born

Exclusion criteria

* Children born before 37th gestational week * Children with a birth weight \< 2500 g * Children suffering from severe chronic illness * Children receiving regular medication * Children who have received antibiotics within a month before intervention start * Children whose parents do not speak Danish

Design outcomes

Primary

MeasureTime frameDescription
Number of days absent from day care due to respiratory and gastrointestinal infectionsUp to 6 monthRecorded weekly by the parents using web-based questionnaires

Secondary

MeasureTime frameDescription
Antibiotic useUp to 6 monthNumber of treatments with antibiotics during the intervention period Recorded weekly by the parents using web-based questionnires
Parental absence from work due to illness of the childUp to 6 monthNumber of days a parent is absent from work due to illness of the child (infections and other illnesses, respectively) Recorded by the parents weekly using web-based questionnaires
Medical visitsUp to 6 monthNumber of visits to a doctor due to infections and other illnesses, respectively. Recorded by the parents using web-based questionnaires
Change from baseline in Thymus sizeAt baseline and after 6 mo (end of intervention)Change in thymic size during intervention period will be evaluated using ultraound
Acute upper respiratory tract infectionsUp to 6 monthNumber of days with acute upper respiratory tract infections (URTI); Number of children with at least 1 episode of URTI; Number of children with at least 3 episodes of URTI; Number of URTI episodes/child/year; Duration of URTI episodes (days); Additionally,symptoms of cold (defined as 2 days with runny/stuffy nose or cough) Recorded by the parents daily/weekly using web-based questionnaires.
Acute lower respiratory infectionsUp to 6 monthNumber of children with at least 1 episode of a lower respiratory tract infection (LRTI). LRTI include bronchitis and pneumonia Recorded by the parents weekly using web-based questionnaires.
Gastrointestinal infectionsUp to 6 monthNumber of children with at least 1 episode of diarrhea; Duration of episodes with diarrhea(days); Number of episodes/child/year with diarrhea; Number of days with vomiting. Recorded by the parents daily using web-based questionnaires
FeverUp to 6 monthNumber of days with fever Recorded by the parents using web-based questionnaires
AllergiesUp to 6 monthNumber of children developing allergies during the intervention period (asthma, allergic rhinitis, atopic dermatitis, food allergies); Age for diagnosis of allergies; Use of medication due to allergies. Recorded by the parents monthly using web-based questionnaires
Absence from day care due to illness other than infectionsUp to 6 monthNumber of days the child is absent from day care due to illness, which is not due to infections. Recorded by the parents weekly using web-based questionnaires

Other

MeasureTime frameDescription
Change from baseline in Biological markers of allergyAt baseline and after 6 moanalysis of biological samples investigating the effect on allergy by biological markers at baseline and at 6 mo
Change from baseline in biological markers for the immune systemAt baseline and after 6 moAnalysis of biological material investigating the effect on the immune system by biological markers .
Change from baseline in biological markers for gastro-intestinal tractAt baseline and after 6 moAnalysis of biological material investigating the effect on the gastrointestinal tract.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026